Q2 2017 Holdings
Filed 2017-07-26 | 11 holdings | $160.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | Common Stock | 699374302 | $62.7K | 2,600,410 | 39.1% |
| Juno Therapeutics | Common Stock | 48205A109 | $36.8K | 1,229,512 | 22.9% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $20.3K | 627,492 | 12.6% |
| Nabriva Therapeutics | Common Stock | G63637105 | $11.9K | 1,139,035 | 7.4% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $8.1K | 579,650 | 5.1% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $6.9K | 1,367,253 | 4.3% |
| Egalet | Common Stock | 28226B104 | $6.8K | 2,889,926 | 4.3% |
| Cidara Therapeutics | Common Stock | 171757107 | $3.3K | 444,965 | 2.1% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $1.7K | 301,477 | 1.1% |
| Essa Pharma | Common Stock | 29668H104 | $933 | 1,696,969 | 0.6% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $708 | 223,457 | 0.4% |